AGÕæÈ˹ٷ½

STOCK TITAN

[8-K] Moleculin Biotech, Inc. Reports Material Event

Filing Impact
(Neutral)
Filing Sentiment
(Neutral)
Form Type
8-K
Rhea-AI Filing Summary

On 6 Aug 2025, Extra Space Storage Inc. (NYSE: EXR) filed a Form 8-K to disclose an Other Events update. The company states that the discussion titled �U.S. Federal Income Tax Consequences� contained in Exhibit 99.1 to this report now supersedes the same-titled section in the prospectus dated 15 Apr 2024 that forms part of its automatic shelf Registration Statement on Form S-3ASR (File Nos. 333-278690 and 333-278690-03). No financial results, guidance, or strategic transactions are included.

The filing’s sole purpose is to ensure investors rely on the most current federal tax analysis when evaluating securities issued under the registration statement. Item 9.01 lists the updated tax exhibit and an Inline XBRL cover-page file. Investors considering purchases under the April 2024 prospectus should review Exhibit 99.1 for the revised tax information.

Il 6 agosto 2025, Extra Space Storage Inc. (NYSE: EXR) ha presentato un modulo 8-K per comunicare un aggiornamento riguardante Altri Eventi. La società dichiara che la sezione intitolata �Conseguenze fiscali federali negli Stati Uniti� contenuta nell'Allegato 99.1 di questo rapporto sostituisce la sezione con lo stesso titolo presente nel prospetto datato 15 aprile 2024, che fa parte della sua dichiarazione di registrazione automatica shelf sul modulo S-3ASR (numeri di fascicolo 333-278690 e 333-278690-03). Non sono inclusi risultati finanziari, previsioni o transazioni strategiche.

Lo scopo esclusivo della presentazione è garantire che gli investitori si basino sull’analisi fiscale federale più aggiornata quando valutano i titoli emessi secondo la dichiarazione di registrazione. L’Elemento 9.01 elenca l’allegato fiscale aggiornato e un file di copertina Inline XBRL. Gli investitori interessati all’acquisto secondo il prospetto di aprile 2024 dovrebbero consultare l’Allegato 99.1 per le informazioni fiscali riviste.

El 6 de agosto de 2025, Extra Space Storage Inc. (NYSE: EXR) presentó un Formulario 8-K para divulgar una actualización de Otros Eventos. La empresa indica que la sección titulada �Consecuencias fiscales federales de EE. UU.� contenida en el Anexo 99.1 de este informe reemplaza la sección con el mismo título en el prospecto fechado el 15 de abril de 2024 que forma parte de su Declaración de Registro automática en estantería en el Formulario S-3ASR (Números de archivo 333-278690 y 333-278690-03). No se incluyen resultados financieros, previsiones ni transacciones estratégicas.

El único propósito de esta presentación es asegurar que los inversores se basen en el análisis fiscal federal más actualizado al evaluar los valores emitidos bajo la declaración de registro. El ítem 9.01 enumera el anexo fiscal actualizado y un archivo de portada Inline XBRL. Los inversores que consideren compras bajo el prospecto de abril de 2024 deben revisar el Anexo 99.1 para la información fiscal revisada.

2025ë…� 8ì›� 6ì�, Extra Space Storage Inc. (NYSE: EXR)ì€ Form 8-Kë¥� 제출하여 기타 사건 ì—…ë°ì´íЏë¥� 공시했습니다. 회사ëŠ� ì� ë³´ê³ ì„œì˜ ë¶€ì†ì„œ 99.1ì—� í¬í•¨ë� â€�미국 ì—°ë°© 소ë“ì„� ì˜í–¥â€ë¼ëŠ� 제목ì� ë…¼ì˜ê°€ 2024ë…� 4ì›� 15ì¼ìž 투ìžì„¤ëª…ì„œì— ìžˆëŠ” ë™ì¼ 제목 섹션ì� 댶Äì²�한다ê³� ë°í˜”으며, 해당 투ìžì„¤ëª…서는 ìžë™ ë“±ë¡ ì„ ë°˜ ì‹ ê³ ì„œì¸ Form S-3ASR(íŒŒì¼ ë²ˆí˜¸ 333-278690 ë°� 333-278690-03)ì� ì¼ë¶€ìž…니ë‹�. 재무 실ì , ì „ë§ ë˜ëŠ” ì „ëžµì � 거래ëŠ� í¬í•¨ë˜ì§€ 않았습니ë‹�.

ì´ë²ˆ 제출ì� 유ì¼í•� 목ì ì€ 투ìžìžë“¤ì� ë“±ë¡ ì‹ ê³ ì„œì— ë”°ë¼ ë°œí–‰ë� ì¦ê¶Œì� í‰ê°€í•� ë•� 최신 ì—°ë°© 세금 ë¶„ì„ì� 신뢰하ë„ë¡� 하는 것입니다. 항목 9.01ì—는 ì—…ë°ì´íЏë� 세금 ë¶€ì†ì„œì™€ Inline XBRL 표지 파ì¼ì� 나열ë˜ì–´ 있습니다. 2024ë…� 4ì›� 투ìžì„¤ëª…ì„œì— ë”°ë¥¸ 구매ë¥� 고려하는 투ìžìžëŠ” 수정ë� 세금 ì •ë³´ë¥� 위해 ë¶€ì†ì„œ 99.1ì� 검토해ì•� 합니ë‹�.

Le 6 août 2025, Extra Space Storage Inc. (NYSE : EXR) a déposé un formulaire 8-K pour divulguer une mise à jour concernant Autres événements. La société indique que la section intitulée « Conséquences fiscales fédérales américaines » contenue dans l'Annexe 99.1 de ce rapport remplace désormais la section du même nom dans le prospectus daté du 15 avril 2024, qui fait partie de sa déclaration d’enregistrement automatique sur formulaire S-3ASR (numéros de dossier 333-278690 et 333-278690-03). Aucun résultat financier, prévision ou transaction stratégique n’est inclus.

Le seul but de ce dépôt est de garantir que les investisseurs s’appuient sur l’analyse fiscale fédérale la plus récente lors de l’évaluation des titres émis en vertu de la déclaration d’enregistrement. L’élément 9.01 liste l’annexe fiscale mise à jour ainsi qu’un fichier de couverture Inline XBRL. Les investisseurs envisageant des achats selon le prospectus d’avril 2024 doivent consulter l’Annexe 99.1 pour les informations fiscales révisées.

Am 6. August 2025 reichte Extra Space Storage Inc. (NYSE: EXR) ein Formular 8-K ein, um ein Update zu Sonstigen Ereignissen bekanntzugeben. Das Unternehmen erklärt, dass die Diskussion mit dem Titel �US-Bundessteuerliche Folgen� im Exhibit 99.1 dieses Berichts nun den gleichnamigen Abschnitt im Prospekt vom 15. April 2024 ersetzt, der Teil der automatischen Shelf-Registrierungserklärung auf Formular S-3ASR (Aktenzeichen 333-278690 und 333-278690-03) ist. Finanzielle Ergebnisse, Prognosen oder strategische Transaktionen sind nicht enthalten.

Der einzige Zweck der Einreichung besteht darin, sicherzustellen, dass Anleger bei der Bewertung von Wertpapieren, die unter der Registrierungserklärung ausgegeben werden, auf die aktuellste bundessteuerliche Analyse zurückgreifen. Punkt 9.01 führt das aktualisierte Steuerexhibit und eine Inline-XBRL-Titelseite auf. Anleger, die Käufe unter dem Prospekt vom April 2024 erwägen, sollten Exhibit 99.1 für die überarbeiteten Steuerinformationen prüfen.

Positive
  • Proactive disclosure: EXR updated its prospectus with current U.S. federal tax guidance, improving transparency for investors using the shelf registration.
Negative
  • None.

Insights

TL;DR � Routine legal update; no financial impact.

This 8-K merely replaces the tax discussion in EXR’s April 2024 shelf prospectus with a refreshed analysis in Exhibit 99.1. Such updates are common for REITs to reflect changes in tax law or clarifications from counsel. There are no changes to capital structure, operations, or earnings outlook. Accordingly, the filing is procedural and should not affect valuation, but investors using the shelf should reference the new exhibit to ensure compliance and accurate tax planning.

Il 6 agosto 2025, Extra Space Storage Inc. (NYSE: EXR) ha presentato un modulo 8-K per comunicare un aggiornamento riguardante Altri Eventi. La società dichiara che la sezione intitolata �Conseguenze fiscali federali negli Stati Uniti� contenuta nell'Allegato 99.1 di questo rapporto sostituisce la sezione con lo stesso titolo presente nel prospetto datato 15 aprile 2024, che fa parte della sua dichiarazione di registrazione automatica shelf sul modulo S-3ASR (numeri di fascicolo 333-278690 e 333-278690-03). Non sono inclusi risultati finanziari, previsioni o transazioni strategiche.

Lo scopo esclusivo della presentazione è garantire che gli investitori si basino sull’analisi fiscale federale più aggiornata quando valutano i titoli emessi secondo la dichiarazione di registrazione. L’Elemento 9.01 elenca l’allegato fiscale aggiornato e un file di copertina Inline XBRL. Gli investitori interessati all’acquisto secondo il prospetto di aprile 2024 dovrebbero consultare l’Allegato 99.1 per le informazioni fiscali riviste.

El 6 de agosto de 2025, Extra Space Storage Inc. (NYSE: EXR) presentó un Formulario 8-K para divulgar una actualización de Otros Eventos. La empresa indica que la sección titulada �Consecuencias fiscales federales de EE. UU.� contenida en el Anexo 99.1 de este informe reemplaza la sección con el mismo título en el prospecto fechado el 15 de abril de 2024 que forma parte de su Declaración de Registro automática en estantería en el Formulario S-3ASR (Números de archivo 333-278690 y 333-278690-03). No se incluyen resultados financieros, previsiones ni transacciones estratégicas.

El único propósito de esta presentación es asegurar que los inversores se basen en el análisis fiscal federal más actualizado al evaluar los valores emitidos bajo la declaración de registro. El ítem 9.01 enumera el anexo fiscal actualizado y un archivo de portada Inline XBRL. Los inversores que consideren compras bajo el prospecto de abril de 2024 deben revisar el Anexo 99.1 para la información fiscal revisada.

2025ë…� 8ì›� 6ì�, Extra Space Storage Inc. (NYSE: EXR)ì€ Form 8-Kë¥� 제출하여 기타 사건 ì—…ë°ì´íЏë¥� 공시했습니다. 회사ëŠ� ì� ë³´ê³ ì„œì˜ ë¶€ì†ì„œ 99.1ì—� í¬í•¨ë� â€�미국 ì—°ë°© 소ë“ì„� ì˜í–¥â€ë¼ëŠ� 제목ì� ë…¼ì˜ê°€ 2024ë…� 4ì›� 15ì¼ìž 투ìžì„¤ëª…ì„œì— ìžˆëŠ” ë™ì¼ 제목 섹션ì� 댶Äì²�한다ê³� ë°í˜”으며, 해당 투ìžì„¤ëª…서는 ìžë™ ë“±ë¡ ì„ ë°˜ ì‹ ê³ ì„œì¸ Form S-3ASR(íŒŒì¼ ë²ˆí˜¸ 333-278690 ë°� 333-278690-03)ì� ì¼ë¶€ìž…니ë‹�. 재무 실ì , ì „ë§ ë˜ëŠ” ì „ëžµì � 거래ëŠ� í¬í•¨ë˜ì§€ 않았습니ë‹�.

ì´ë²ˆ 제출ì� 유ì¼í•� 목ì ì€ 투ìžìžë“¤ì� ë“±ë¡ ì‹ ê³ ì„œì— ë”°ë¼ ë°œí–‰ë� ì¦ê¶Œì� í‰ê°€í•� ë•� 최신 ì—°ë°© 세금 ë¶„ì„ì� 신뢰하ë„ë¡� 하는 것입니다. 항목 9.01ì—는 ì—…ë°ì´íЏë� 세금 ë¶€ì†ì„œì™€ Inline XBRL 표지 파ì¼ì� 나열ë˜ì–´ 있습니다. 2024ë…� 4ì›� 투ìžì„¤ëª…ì„œì— ë”°ë¥¸ 구매ë¥� 고려하는 투ìžìžëŠ” 수정ë� 세금 ì •ë³´ë¥� 위해 ë¶€ì†ì„œ 99.1ì� 검토해ì•� 합니ë‹�.

Le 6 août 2025, Extra Space Storage Inc. (NYSE : EXR) a déposé un formulaire 8-K pour divulguer une mise à jour concernant Autres événements. La société indique que la section intitulée « Conséquences fiscales fédérales américaines » contenue dans l'Annexe 99.1 de ce rapport remplace désormais la section du même nom dans le prospectus daté du 15 avril 2024, qui fait partie de sa déclaration d’enregistrement automatique sur formulaire S-3ASR (numéros de dossier 333-278690 et 333-278690-03). Aucun résultat financier, prévision ou transaction stratégique n’est inclus.

Le seul but de ce dépôt est de garantir que les investisseurs s’appuient sur l’analyse fiscale fédérale la plus récente lors de l’évaluation des titres émis en vertu de la déclaration d’enregistrement. L’élément 9.01 liste l’annexe fiscale mise à jour ainsi qu’un fichier de couverture Inline XBRL. Les investisseurs envisageant des achats selon le prospectus d’avril 2024 doivent consulter l’Annexe 99.1 pour les informations fiscales révisées.

Am 6. August 2025 reichte Extra Space Storage Inc. (NYSE: EXR) ein Formular 8-K ein, um ein Update zu Sonstigen Ereignissen bekanntzugeben. Das Unternehmen erklärt, dass die Diskussion mit dem Titel �US-Bundessteuerliche Folgen� im Exhibit 99.1 dieses Berichts nun den gleichnamigen Abschnitt im Prospekt vom 15. April 2024 ersetzt, der Teil der automatischen Shelf-Registrierungserklärung auf Formular S-3ASR (Aktenzeichen 333-278690 und 333-278690-03) ist. Finanzielle Ergebnisse, Prognosen oder strategische Transaktionen sind nicht enthalten.

Der einzige Zweck der Einreichung besteht darin, sicherzustellen, dass Anleger bei der Bewertung von Wertpapieren, die unter der Registrierungserklärung ausgegeben werden, auf die aktuellste bundessteuerliche Analyse zurückgreifen. Punkt 9.01 führt das aktualisierte Steuerexhibit und eine Inline-XBRL-Titelseite auf. Anleger, die Käufe unter dem Prospekt vom April 2024 erwägen, sollten Exhibit 99.1 für die überarbeiteten Steuerinformationen prüfen.

false 0001659617 0001659617 2025-08-06 2025-08-06
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
 
FORM 8-K
 
CURRENT REPORT
 
PURSUANT TO SECTION 13 OR 15(D) OF THE SECURITIES EXCHANGE ACT OF 1934
 
DATE OF REPORT (DATE OF EARLIEST EVENT REPORTED): August 6, 2025
 
logobig.jpg
 
 
MOLECULIN BIOTECH, INC.
(Exact Name of Registrant as Specified in its Charter)
 
Delaware
001-37758
47-4671997
(State or Other Jurisdiction of
Incorporation or Organization)
(Commission File No.)
(I.R.S. Employer Identification
No.)
 
5300 Memorial Drive, Suite 950, Houston, TX 77007
(Address of principal executive offices and zip code)
 
(713) 300-5160
(Registrant’s telephone number, including area code)
 
(Former name or former address, if changed from last report)
 
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):
 
Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-14(c))
 
Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).          Emerging growth company 
 
If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐
 
Securities registered pursuant to Section 12(b) of the Act:
 
Title of each class
Trading Symbol (s)
Name of each exchange on which registered
Common Stock, par value $.001 per share
MBRX
The NASDAQ Stock Market LLC
 
 

 
 
Item 7.01
Regulation FD Disclosure
 
On August 6, 2025, Moleculin Biotech, Inc. (the “Company”), issued a press release which announced the presentation of encouraging preclinical data for its lead drug candidate, Annamycin, also known by its non-proprietary name of naxtarubicin, which demonstrated significant efficacy against various primary and metastatic liver cancers, including hepatocellular carcinoma (HCC), colorectal liver metastases, and pancreatic ductal adenocarcinoma (PDAC) liver metastases. This is believed to be the result of targeted accumulation in the liver and other organs.
 
These findings were highlighted in a poster entitled “Liposomal Annamycin (L-ANN) Efficacy Against Primary and Metastatic Liver Cancers,” presented by Dr. Waldemar Priebe, Lead Author and Chairman of the Scientific Advisory Board at Moleculin at the recently held Shelby-Lavine Pancreatic Cancer Symposium at MD Anderson Cancer Center.
 
A copy of the press release and poster are attached to this report as Exhibit 99.1 and 99.2, respectively, and are incorporated by reference herein.
 
The information contained in Item 7.01 of this Current Report on Form 8-K, including Exhibits 99.1 and 99.2, is being furnished and shall not be “filed” for the purpose of the Securities Exchange Act of 1934, as amended (“Exchange Act”), nor shall it be incorporated by reference in any filing under the Exchange Act or the Securities Act of 1933, as amended (“Securities Act”), unless specifically identified therein as being incorporated by reference.
 
Item 9.01
Financial Statements and Exhibits.
 
(d)
Exhibits.
 
Exhibit
No.
Description
 
99.1
Press Release dated August 6, 2025
 
 
99.2
Liposomal Annamycin (L-ANN) Efficacy against primary and Metastatic Liver Cancers poster
 
104
Cover page Interactive Data File (formatted as Inline XBRL document)
 
 
 
SIGNATURE
 
Pursuant to the requirements of the Securities and Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
 
 
MOLECULIN BIOTECH, INC. 
 
       
       
 
Date:
August 6, 2025
 
       
 
By:
/s/ Jonathan P. Foster
 
   
Jonathan P. Foster
 
 
 
 

FAQ

Why did Extra Space Storage (EXR) file an 8-K on August 6 2025?

To notify investors that Exhibit 99.1 provides an updated U.S. Federal Income Tax Consequences discussion, replacing the version in the April 15 2024 prospectus.

Does the filing include any new financial results or earnings data for EXR?

No. The 8-K contains no financial statements, guidance, or earnings metrics; it is strictly a legal disclosure update.

Which document is superseded by Exhibit 99.1?

The tax consequences section in the prospectus that forms part of EXR’s Form S-3ASR Registration Statement filed on April 15 2024.

Where can investors review the updated tax information?

The full text is in Exhibit 99.1 to this Form 8-K, available through the SEC’s EDGAR system under EXR’s filings.

Are there any other exhibits included in this 8-K?

Yes. Exhibit 104 contains the Inline XBRL cover-page tags embedded within the document.
Moleculin Biotec

NASDAQ:MBRX

MBRX Rankings

MBRX Latest News

MBRX Latest SEC Filings

MBRX Stock Data

20.68M
29.14M
3.53%
4.89%
17.31%
Biotechnology
Pharmaceutical Preparations
United States
HOUSTON